44% of Americans Now Own Health Wearables, Up From 33% in 2019
Rock Health's annual Digital Health Consumer Adoption Survey finds wearable health device ownership has jumped 10 points since 2019, with 86% of patients reporting improved health outcomes from wearable technology.
Read the original article at Rock HealthKairos™'s Take
Kairos™'s perspective on this story
The shift toward patient-owned health data is accelerating. Rock Health's annual Digital Health Consumer Adoption Survey reports that 44% of Americans now own wearable health tracking devices such as smartwatches, fitness bands, or smart rings, up from 33% in 2019. The global market for healthcare wearables was valued at $33.85 billion in 2023 and is projected to reach $250 billion by 2030, reflecting a fundamental change in how people engage with their own health data.
The demographics of adoption are revealing. Ownership is highest among younger, higher-income, and more educated populations, and those living in urban areas. But the data also shows encouraging trends in health equity: non-Hispanic Black and Hispanic/Latine respondents had higher odds of owning a wearable than non-Hispanic white counterparts, suggesting that the technology is reaching diverse populations, not just early-adopter demographics.
The perceived value is high. Eighty-six percent of patients report that wearable medical devices improve their health outcomes. This is not just step counting; modern wearables track heart rate variability, sleep staging, blood oxygen, skin temperature, and menstrual cycle data. The data these devices generate is increasingly clinical in quality, though integration with traditional healthcare records remains fragmented.
The COVID-19 pandemic accelerated adoption by heightening awareness of personal health monitoring. But the sustained post-pandemic growth suggests this is a permanent behavioral shift, not a temporary response to crisis.
The Tracking Connection
Kairos™ builds on the wearable revolution by adding the clinical layer that wearables alone cannot provide. Step counts and sleep scores are useful, but they become powerful when integrated with lab results, hormonal trends, symptom tracking, and screening schedules. Kairos is the connective tissue between consumer health data and clinical intelligence, turning raw metrics into actionable health trajectories.
Ready to start tracking?
Kairos™ tracks, scores, and interprets the symptoms of midlife hormonal change — for both women and men.
Get StartedMore from the newsroom
Longitudinal Health Monitoring Can Predict Disease 5-7 Years Before Diagnosis
Research on digital biomarker monitoring shows that longitudinal tracking of health data can identify high-risk individuals years before clinical diagnosis, enabling targeted prevention for type 2 diabetes, cardiovascular disease, and other chronic conditions.
Untreated Menopause Costs the US $26.6 Billion Per Year, Mayo Clinic Finds
A Mayo Clinic study finds menopause symptoms cost $1.8 billion annually in lost work time and $26.6 billion when medical expenses are added, with 13% of working women reporting at least one adverse work outcome due to symptoms.
USPSTF Screening Guidelines: What Adults Should Be Testing and When
The USPSTF's Grade A and B recommendations cover depression, diabetes, hypertension, and cancer screening for adults, yet most Americans do not follow the recommended schedule, missing early detection opportunities.